THE UNIVERSITY OF SYDNEY
🇦🇺Australia
Clinical Trials
391
Active:26
Completed:125
Trial Phases
5 Phases
Phase 1:6
Phase 2:48
Phase 3:18
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (378 trials with phase data)• Click on a phase to view related trials
Not Applicable
298 (78.8%)Phase 2
48 (12.7%)Phase 3
18 (4.8%)Phase 4
8 (2.1%)Phase 1
6 (1.6%)No trials found
News
Medidata Expands Partnership with University of Sydney to Accelerate Clinical Trial Innovation
Medidata has expanded its six-year partnership with the NHMRC Clinical Trials Centre at the University of Sydney, now supporting 30 concurrent studies through its unified platform.
Strand Therapeutics Reports Promising Phase 1 Data for Novel mRNA Cancer Therapy STX-001
Strand Therapeutics announced preliminary Phase 1 data for STX-001, a self-replicating mRNA therapy encoding IL-12, showing favorable safety and encouraging anti-tumor activity in 22 patients with checkpoint inhibitor-refractory solid tumors.